Loading...
•
Dec 31, 2024
Strata Critical Medical Q4 2024 Earnings Report
Blade Air Mobility reported strong revenue growth and significant improvement in profitability for Q4 2024.
Key Takeaways
Blade's Q4 2024 revenue grew by 14.5% to $54.4 million, driven by strong performance in the Medical segment. Net loss improved by 71.1% to $9.8 million, and Adjusted EBITDA saw a substantial improvement, reaching near break-even at $(0.4) million. Flight profit increased by 39.7%, with a flight margin expansion to 23.2%.
Revenue increased 14.5% to $54.4 million.
Net loss improved 71.1% to $(9.8) million.
Flight profit grew 39.7% to $12.6 million.
Adjusted EBITDA improved to $(0.4) million from $(5.2) million last year.
Forward Guidance
Blade expects revenue between $245M and $265M in 2025, with projected double-digit Adjusted EBITDA growth.
Positive Outlook
- Projected revenue range of $245M to $265M for 2025.
- Expecting double-digit Adjusted EBITDA growth in 2025.
- Continued focus on medical segment expansion.
- Increased investment in eVTOL infrastructure.
- Strategic partnerships to enhance urban air mobility services.
Challenges Ahead
- Potential impact of cost inflation on flight operations.
- Lower passenger flight volumes compared to prior year.
- Ongoing restructuring expenses in Europe.
- Increased regulatory costs affecting operations.
- Macroeconomic conditions may impact consumer travel demand.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...